Abdelsalam SS, Korashy HM, Zeidan A, Agouni A (2019) The role of protein tyrosine phosphatase (PTP)-1B in cardiovascular disease and its interplay with insulin resistance. Biomolecules 9(7):286
Article CAS PubMed PubMed Central Google Scholar
Athar T, Al Balushi K, Khan SA (2021) Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease. Mol Biol Rep 48(7):5629–5645
Article CAS PubMed PubMed Central Google Scholar
Bai R, Guo J, Ye XY, Xie Y, Xie T (2022) Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease. Ageing Res Rev 77:101619
Article CAS PubMed Google Scholar
Brenowitz WD, Xiang Y, McEvoy CT, Yang C, Yaffe K, Le WD et al (2021) Current Alzheimer disease research highlights: evidence for novel risk factors. Chin Med J (Engl) 134(18):2150–2159
Article CAS PubMed Google Scholar
Ceylan H (2022) Integrated bioinformatics analysis to identify alternative therapeutic targets for Alzheimer’s disease: insights from a synaptic machinery perspective. J Mol Neurosci 72(2):273–286
Article CAS PubMed Google Scholar
Chen N, Wang J, He Y, Xu Y, Zhang Y, Gong Q et al (2020) Trilobatin protects against abeta25-35-induced hippocampal HT22 cells apoptosis through mediating ROS/p38/caspase 3-dependent pathway. Front Pharmacol 11:584
Article CAS PubMed PubMed Central Google Scholar
Chen X, Drew J, Berney W, Lei W (2021) Neuroprotective natural products for Alzheimer’s disease. Cells 10(6):1309
Article CAS PubMed PubMed Central Google Scholar
Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357–W364
Article CAS PubMed PubMed Central Google Scholar
Ding Y, Zhang H, Liu Z, Li Q, Guo Y, Chen Y et al (2021) Carnitine palmitoyltransferase 1 (CPT1) alleviates oxidative stress and apoptosis of hippocampal neuron in response to beta-Amyloid peptide fragment Abeta25-35. Bioengineered 12(1):5440–5449
Article CAS PubMed PubMed Central Google Scholar
Forman HJ, Zhang H (2021) Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov 20(9):689–709
Article CAS PubMed PubMed Central Google Scholar
Ghasemi R, Zarifkar A, Rastegar K, Maghsoudi N, Moosavi M (2014) Insulin protects against Abeta-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption. Neuropharmacology 85:113–120
Article CAS PubMed Google Scholar
Hou TY, Zhou Y, Zhu LS, Wang X, Pang P, Wang DQ et al (2020) Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer’s disease. J Neurochem 154(4):441–457
Article CAS PubMed Google Scholar
Jin T, Li D, Yang T, Liu F, Kong J, Zhou Y (2019) PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival. Oncol Rep 42(2):717–725
Karran E, De Strooper B (2022) The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov 21(4):306–318
Article CAS PubMed Google Scholar
Khan A, Ali A, Junaid M, Liu C, Kaushik AC, Cho WCS, Wei DQ (2018) Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network. BMC Syst Biol 12(Suppl 4):39
Article PubMed PubMed Central Google Scholar
Kim GJ, Song DH, Yoo HS, Chung KH, Lee KJ, An JH (2017) Hederagenin supplementation alleviates the pro-inflammatory and apoptotic response to alcohol in rats. Nutrients 9(1):41
Article PubMed PubMed Central Google Scholar
Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT et al (2021) Alzheimer disease. Nat Rev Dis Primers 7(1):33
Article PubMed PubMed Central Google Scholar
Kostrzewa T, Styszko J, Gorska-Ponikowska M, Sledzinski T, Kuban-Jankowska A (2019) Inhibitors of protein tyrosine phosphatase PTP1B with anticancer potential. Anticancer Res 39(7):3379–3384
Article CAS PubMed Google Scholar
Liang B, Li C, Zhao J (2016) Identification of key pathways and genes in colorectal cancer using bioinformatics analysis. Med Oncol 33(10):111
Liang BF, Huang F, Wang HT, Wang GH, Yuan X, Zhang MZ et al (2015) Involvement of norepinephrine and serotonin system in antidepressant-like effects of hederagenin in the rat model of unpredictable chronic mild stress-induced depression. Pharm Biol 53(3):368–377
Article CAS PubMed Google Scholar
Liang W, Xie Z, Liao D, Li Y, Li Z, Zhao Y et al (2023) Inhibiting microRNA-142-5p improves learning and memory in Alzheimer’s disease rats via targeted regulation of the PTPN1-mediated Akt pathway. Brain Res Bull 192:107–114
Article CAS PubMed Google Scholar
Lin P, Sun J, Cheng Q, Yang Y, Cordato D, Gao J (2021a) The development of pharmacological therapies for Alzheimer’s disease. Neurol Ther 10(2):609–626
Article PubMed PubMed Central Google Scholar
Lin R, Liu L, Silva M, Fang J, Zhou Z, Wang H et al (2021b) Hederagenin protects PC12 cells against corticosterone-induced injury by the activation of the PI3K/AKT pathway. Front Pharmacol 12:712876
Article CAS PubMed PubMed Central Google Scholar
Liu N, Zhang T, Sun J, Yao J, Ma L, Fu J et al (2021) An overview of systematic reviews of Chinese herbal medicine for Alzheimer’s disease. Front Pharmacol 12:761661
Article PubMed PubMed Central Google Scholar
Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC (2021) PI3K/AKt signal pathway: A target of natural products in the prevention and treatment of Alzheimer’s disease and Parkinson’s disease. Front Pharmacol 12:648636
Article CAS PubMed PubMed Central Google Scholar
Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ et al (2022) Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention. Ageing Res Rev 74:101544
Article CAS PubMed Google Scholar
Nandi S, Saxena M (2020) Potential inhibitors of protein tyrosine phosphatase (PTP1B) enzyme: Promising target for type-II diabetes mellitus. Curr Top Med Chem 20(29):2692–2707
Article CAS PubMed Google Scholar
Pinero J, Ramirez-Anguita JM, Sauch-Pitarch J, Ronzano F, Centeno E, Sanz F et al (2020) The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 48(D1):D845–D855
Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A (2022) Hippocampus and its involvement in Alzheimer’s disease: A review. 3 Biotech 12(2):55
Article PubMed PubMed Central Google Scholar
Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Zoghi A, Shanaki-Bavarsad M, Bashash D (2021) The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress? Cell Stress Chaperones 26(6):871–887
Article CAS PubMed PubMed Central Google Scholar
Ren X, Zhang J, Zhao Y, Sun L (2022) Senegenin inhibits abeta1-42-induced PC12 cells apoptosis and oxidative stress via activation of the PI3K/Akt signaling pathway. Neuropsychiatr Dis Treat 18:513–524
Article CAS PubMed PubMed Central Google Scholar
Safran M, Rosen N, Twik M, BarShir R, Stein TI, Dahary D et al (2021) The genecards suite. In: Abugessaisa I, Kasukawa T (eds) Practical Guide to Life Science Databases. Springer Nature Singapore, Singapore, pp 27–56. https://doi.org/10.1007/978-981-16-5812-9_2
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE et al (2021) Alzheimer’s disease. Lancet 397(10284):1577–1590
Article CAS PubMed PubMed Central Google Scholar
Schramm C, Wallon D, Nicolas G, Charbonnier C (2022) What contribution can genetics make to predict the risk of Alzheimer’s disease? Rev Neurol (paris) 178(5):414–421
Article CAS PubMed Google Scholar
Sharma B, Xie L, Yang F, Wang W, Zhou Q, Xiang M et al (2020) Recent advance on PTP1B inhibitors and their biomedical applications. Eur J Med Chem 199:112376
Article CAS PubMed Google Scholar
Sharma VK, Singh TG, Singh S, Garg N, Dhiman S (2021) Apoptotic pathways and Alzheimer’s disease: Probing therapeutic potential. Neurochem Res 46(12):3103–3122
Comments (0)